BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 22022427)

  • 1. Notch ankyrin repeat domain variation influences leukemogenesis and Myc transactivation.
    Aster JC; Bodnar N; Xu L; Karnell F; Milholland JM; Maillard I; Histen G; Nam Y; Blacklow SC; Pear WS
    PLoS One; 2011; 6(10):e25645. PubMed ID: 22022427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Essential roles for ankyrin repeat and transactivation domains in induction of T-cell leukemia by notch1.
    Aster JC; Xu L; Karnell FG; Patriub V; Pui JC; Pear WS
    Mol Cell Biol; 2000 Oct; 20(20):7505-15. PubMed ID: 11003647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia.
    Durinck K; Wallaert A; Van de Walle I; Van Loocke W; Volders PJ; Vanhauwaert S; Geerdens E; Benoit Y; Van Roy N; Poppe B; Soulier J; Cools J; Mestdagh P; Vandesompele J; Rondou P; Van Vlierberghe P; Taghon T; Speleman F
    Haematologica; 2014 Dec; 99(12):1808-16. PubMed ID: 25344525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
    Hales EC; Taub JW; Matherly LH
    Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Notch signaling expands a pre-malignant pool of T-cell acute lymphoblastic leukemia clones without affecting leukemia-propagating cell frequency.
    Blackburn JS; Liu S; Raiser DM; Martinez SA; Feng H; Meeker ND; Gentry J; Neuberg D; Look AT; Ramaswamy S; Bernards A; Trede NS; Langenau DM
    Leukemia; 2012 Sep; 26(9):2069-78. PubMed ID: 22538478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haploinsufficiency of the c-myc transcriptional repressor FIR, as a dominant negative-alternative splicing model, promoted p53-dependent T-cell acute lymphoblastic leukemia progression by activating Notch1.
    Matsushita K; Kitamura K; Rahmutulla B; Tanaka N; Ishige T; Satoh M; Hoshino T; Miyagi S; Mori T; Itoga S; Shimada H; Tomonaga T; Kito M; Nakajima-Takagi Y; Kubo S; Nakaseko C; Hatano M; Miki T; Matsuo M; Fukuyo M; Kaneda A; Iwama A; Nomura F
    Oncotarget; 2015 Mar; 6(7):5102-17. PubMed ID: 25671302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Notch dimerization is required for leukemogenesis and T-cell development.
    Liu H; Chi AW; Arnett KL; Chiang MY; Xu L; Shestova O; Wang H; Li YM; Bhandoola A; Aster JC; Blacklow SC; Pear WS
    Genes Dev; 2010 Nov; 24(21):2395-407. PubMed ID: 20935071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TLX1 and NOTCH coregulate transcription in T cell acute lymphoblastic leukemia cells.
    Riz I; Hawley TS; Luu TV; Lee NH; Hawley RG
    Mol Cancer; 2010 Jul; 9():181. PubMed ID: 20618946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The common oncogenomic program of NOTCH1 and NOTCH3 signaling in T-cell acute lymphoblastic leukemia.
    Choi SH; Severson E; Pear WS; Liu XS; Aster JC; Blacklow SC
    PLoS One; 2017; 12(10):e0185762. PubMed ID: 29023469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The NOTCH1-MYC highway toward T-cell acute lymphoblastic leukemia.
    Sanchez-Martin M; Ferrando A
    Blood; 2017 Mar; 129(9):1124-1133. PubMed ID: 28115368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenesis of T-ALL and nonmalignant consequences of overexpressing intracellular NOTCH1.
    Li X; Gounari F; Protopopov A; Khazaie K; von Boehmer H
    J Exp Med; 2008 Nov; 205(12):2851-61. PubMed ID: 18981238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma.
    Weng AP; Millholland JM; Yashiro-Ohtani Y; Arcangeli ML; Lau A; Wai C; Del Bianco C; Rodriguez CG; Sai H; Tobias J; Li Y; Wolfe MS; Shachaf C; Felsher D; Blacklow SC; Pear WS; Aster JC
    Genes Dev; 2006 Aug; 20(15):2096-109. PubMed ID: 16847353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extension of the Notch intracellular domain ankyrin repeat stack by NRARP promotes feedback inhibition of Notch signaling.
    Jarrett SM; Seegar TCM; Andrews M; Adelmant G; Marto JA; Aster JC; Blacklow SC
    Sci Signal; 2019 Nov; 12(606):. PubMed ID: 31690634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High selective pressure for Notch1 mutations that induce Myc in T-cell acute lymphoblastic leukemia.
    Chiang MY; Wang Q; Gormley AC; Stein SJ; Xu L; Shestova O; Aster JC; Pear WS
    Blood; 2016 Nov; 128(18):2229-2240. PubMed ID: 27670423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RUNX1 is required for oncogenic
    Choi A; Illendula A; Pulikkan JA; Roderick JE; Tesell J; Yu J; Hermance N; Zhu LJ; Castilla LH; Bushweller JH; Kelliher MA
    Blood; 2017 Oct; 130(15):1722-1733. PubMed ID: 28790107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated Notch counteracts Ikaros tumor suppression in mouse and human T-cell acute lymphoblastic leukemia.
    Witkowski MT; Cimmino L; Hu Y; Trimarchi T; Tagoh H; McKenzie MD; Best SA; Tuohey L; Willson TA; Nutt SL; Busslinger M; Aifantis I; Smyth GK; Dickins RA
    Leukemia; 2015 Jun; 29(6):1301-11. PubMed ID: 25655195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A microRNA-mediated regulatory loop modulates NOTCH and MYC oncogenic signals in B- and T-cell malignancies.
    Ortega M; Bhatnagar H; Lin AP; Wang L; Aster JC; Sill H; Aguiar RC
    Leukemia; 2015 Apr; 29(4):968-76. PubMed ID: 25311243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-Catenin is required for T-cell leukemia initiation and MYC transcription downstream of Notch1.
    Gekas C; D'Altri T; Aligué R; González J; Espinosa L; Bigas A
    Leukemia; 2016 Oct; 30(10):2002-2010. PubMed ID: 27125305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth suppression of pre-T acute lymphoblastic leukemia cells by inhibition of notch signaling.
    Weng AP; Nam Y; Wolfe MS; Pear WS; Griffin JD; Blacklow SC; Aster JC
    Mol Cell Biol; 2003 Jan; 23(2):655-64. PubMed ID: 12509463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ZFX controls propagation and prevents differentiation of acute T-lymphoblastic and myeloid leukemia.
    Weisberg SP; Smith-Raska MR; Esquilin JM; Zhang J; Arenzana TL; Lau CM; Churchill M; Pan H; Klinakis A; Dixon JE; Mirny LA; Mukherjee S; Reizis B
    Cell Rep; 2014 Feb; 6(3):528-40. PubMed ID: 24485662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.